Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center

Clinical Infectious Diseases

Volumn 34, Issue 7, 2002, Pages 922-929

  Lodise, Thomas P ^a   McKinnon, Peggy S ^a   Tam, Vincent H ^a   Rybak, Michael J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STRAIN DIFFERENCE; SURVIVAL RATE;

ANALYSIS OF VARIANCE; BACTEREMIA; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); TRAUMA CENTERS; VANCOMYCIN RESISTANCE;

EID: 0036531889     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339211     Document Type: Article

References (26)

1. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
2. Nosocomial enterococci resistance to vancomycin - United States, 1989-1993
3. Nosocomial enterococcal blood stream infections in the SCOPE Program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy
4. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium
5. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality
6. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?
7. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality
8. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
9. Enterococcal bacteremia in the surgical intensive care unit: Does vancomycin resistance affect mortality?
10. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients
11. Risk factors for mortality associated with enterococcal bloodstream infections
12. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
13. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
14. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
15. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcomes for vancomycin-resistant and -susceptible enterococcal bacteremia
16. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia
17. CDC definitions for nosocomial infections, 1988
18. Hospital-acquired candidemia: The attributable mortality and excess length of stay
19. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
20. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
21. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
22. Apache II: A severity of disease classification system
23. Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to total hospital deaths